Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
88.66
+0.63 (0.72%)
At close: Dec 19, 2024, 4:00 PM
88.17
-0.49 (-0.55%)
Pre-market: Dec 20, 2024, 8:13 AM EST
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 96.41, with a low estimate of 68 and a high estimate of 110. The average target predicts an increase of 8.74% from the current stock price of 88.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BSX stock from 23 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 11 | 11 | 11 |
| Buy | 7 | 7 | 7 | 9 | 9 | 9 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 21 | 23 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +24.07% | Dec 18, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $100 → $110 | Buy | Maintains | $100 → $110 | +24.07% | Dec 16, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +24.07% | Dec 12, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $98 → $107 | Strong Buy | Maintains | $98 → $107 | +20.69% | Dec 11, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $98 → $100 | Buy | Maintains | $98 → $100 | +12.79% | Dec 11, 2024 |
Financial Forecast
Revenue This Year
16.74B
from 14.24B
Increased by 17.57%
Revenue Next Year
18.80B
from 16.74B
Increased by 12.29%
EPS This Year
2.49
from 1.07
Increased by 132.50%
EPS Next Year
2.82
from 2.49
Increased by 13.28%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 17.5B | 20.3B | 22.5B | |||
| Avg | 16.7B | 18.8B | 20.7B | |||
| Low | 16.0B | 17.9B | 19.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 23.1% | 21.3% | 19.8% | |||
| Avg | 17.6% | 12.3% | 10.2% | |||
| Low | 12.7% | 6.6% | 3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.60 | 3.01 | 3.47 | |||
| Avg | 2.49 | 2.82 | 3.20 | |||
| Low | 2.39 | 2.67 | 2.97 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 143.4% | 21.1% | 22.9% | |||
| Avg | 132.5% | 13.3% | 13.6% | |||
| Low | 123.5% | 7.1% | 5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.